Señales en vivo de AGLE | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 nov 2023 @ 16:00):

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases...

Stats
Volumen de hoy	43 238
Volumen promedio	59 537
Capitalización de mercado	48.63M
EPS	$-9.34 ( Q3 \| 2023-11-09 )
Próxima fecha de ganancias	( $0 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.162 (Sector) 42.63 (Industry) 24.32
ATR14	$2.39 (12.36%)

AADI -5.88%

ABCL 2.16%

ABCM 0.04%

ABEO -3.08%

ABIO -1.68%

ABOS 4.67%

ABSI 4.93%

ABUS -0.98%

ABVX -1.97%

ACAD -0.08%

ACER -17.95%

ACET -8.56%

ACGN 1.29%

ACHL -1.63%

ACHV 3.02%

ACIU -2.00%

ACLX 0.37%

ACRV -4.71%

ACST -4.89%

ACXP 3.93%

ADAG 6.12%

ADAP -2.98%

ADGI 0.87%

ADIL 0.88%

ADMA -2.04%

ADPT 0.30%

ADTX -2.78%

ADVM 1.01%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.92%

AGEN -3.03%

AGIO -2.03%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 4.67%

AKRO -2.85%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.89%

ALGS 1.32%

ALKS 1.43%

ALLK -11.49%

ALLO -3.96%

ALLR -3.77%

ALNA 3.16%

ALNY 2.77%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -13.42%

ALVR -0.69%

ALXN 0.00%

ALXO -13.32%

ALZN 4.02%

AMRN -2.21%

AMTI -3.13%

ANAB 1.38%

ANEB 6.06%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 1.97%

ANPC -3.15%

APGE 0.12%

APGN 8.48%

APGNW 30.65%

APLM -4.60%

APLS 0.77%

APLT -0.68%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 4.82%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.46%

ARDS -12.13%

ARDX 1.33%

ARGX -0.37%

ARNA 0.00%

ARPO -0.90%

ARQT -2.71%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.56%

ARWR -1.86%

ASLN -3.27%

ASMB -4.87%

ASND -2.05%

ATAI -3.33%

ATHA 7.31%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.34%

ATRA -3.48%

ATXI 2.70%

ATXS -0.67%

AUPH -0.81%

AURA 4.54%

AUTL -3.30%

AVBP -3.66%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.34%

AVTX -3.74%

AVXL -5.06%

AXLA 0.00%

AXSM -1.26%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.22%

BCAB -2.61%

BCDA -3.15%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.44%

BCTX 8.16%

BCTXW 13.02%

BCYC 1.15%

BDRX -2.43%

BDTX -0.43%

BEAM 2.56%

BFRA -2.91%

BGNE -2.07%

BIOR -5.27%

BIVI 2.90%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.39%

BLTE -1.03%

BLU 0.03%

BLUE -1.83%

BMEA -12.97%

BMRN 0.32%

BNOX 6.15%

BNTC -1.69%

BNTX -1.60%

BOLD -8.36%

BOLT -0.09%

BPMC -1.13%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -6.10%

BTAI 16.78%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.95%

CABA 0.83%

CADL 0.35%

CALA 0.00%

CALC -3.74%

CALT -1.59%

CAPR -1.29%

CARA -3.23%

CARM 6.93%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.44%

CCXI 0.00%

CDAK 0.00%

CDIO -4.99%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -0.81%

CDTTW -39.60%

CDTX -4.86%

CDXC 7.16%

CDXS 8.97%

CELC -3.03%

CELU -1.83%

CELUW 11.80%

CERC -1.68%

CERE -1.52%

CERO -8.39%

CEROW -10.18%

CFRX -27.95%

CGEM -0.24%

CGEN -3.87%

CGON -1.42%

CGTX -4.35%

CHMA -6.00%

CHRS 3.48%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.79%

CLBS -16.75%

CLDX -1.10%

CLGN 0.70%

CLLS -3.63%

CLNN 1.36%

CLNNW 0.00%

CLRB 7.06%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.65%

CMPI 0.00%

CMPX -0.95%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.42%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.11%

CNTB -0.75%

CNTX -4.78%

COCP -2.00%

COEPW 32.45%

COGT -2.64%

CORT 2.24%

COYA 1.16%

CPRX -1.91%

CRBP -0.97%

CRBU -6.82%

CRDF 1.33%

CRGX 0.27%

CRIS -3.19%

CRNX -6.31%

CRSP -0.32%

CRTX 2.63%

CRVO -3.25%

CRVS 0.56%

CSBR 0.11%

CTCX -1.59%

CTIC 0.06%

CTMX -2.89%

CTNM 2.01%

CTXR 0.07%

CUE -1.73%

CVAC -8.05%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.69%

CYTO 0.91%

DARE 3.55%

DAWN -1.04%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.09%

DNLI -1.72%

DNTH -4.74%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 1.43%

DSGN -3.17%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -2.82%

EDSA 4.09%

EFTR 3.51%

EFTRW -53.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.82%

ELEV -3.73%

ELOX 10.77%

ELTX -5.15%

ELVN -1.77%

ELYM 4.60%

ENGN -0.25%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA 0.08%

ENTO -4.97%

ENTX -0.53%

ENVB 8.30%

EPIX -0.73%

EPRX -1.92%

EPZM 0.00%

EQ 0.18%

EQRX -2.09%

EQRXW 0.00%

ERAS 0.00%

ERNA -2.83%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.07%

ETON 3.35%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.64%

EXAI -0.24%

EXEL 0.38%

EYEG -0.69%

EYEN 0.68%

EYPT 1.45%

FATE -11.42%

FBIO 0.90%

FBIOP 0.87%

FBLG -8.00%

FBRX -0.02%

FDMT -4.82%

FENC -2.43%

FGEN -9.83%

FHTX 7.82%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.47%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.80%

FULC 1.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 0.00%

GANX -1.54%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.31%

GHRS -3.72%

GLMD -4.09%

GLPG -1.52%

GLSI 3.97%

GLTO -3.31%

GLUE -3.43%

GLYC -12.17%

GMAB -0.27%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.64%

GNPX -2.86%

GNTA 3.94%

GOSS -11.51%

GOVX -0.91%

GOVXW 10.89%

GPCR -6.21%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.48%

GRTX -1.66%

GTHX -0.68%

GUTS 3.00%

GXGXW 41.67%

GYRE -4.44%

HALO -1.76%

HARP 0.09%

HCWB -6.13%

HEPA -3.14%

HGEN -84.62%

HILS 5.66%

HLVX -2.30%

HOOK 0.89%

HOTH -1.62%

HOWL 1.30%

HRMY 4.37%

HRTX 8.52%

HSTO 0.00%

HUMA 1.32%

HUMAW -6.26%

IBRX -5.50%

ICCC -4.42%

ICPT 0.21%

ICU 18.61%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -3.13%

IFRX -2.47%

IGMS -1.32%

IKNA -0.30%

IKT -9.86%

IMAB 0.00%

IMCR -3.12%

IMGN 0.02%

IMGO 0.00%

IMMP 4.36%

IMMX -5.65%

IMNM 3.55%

IMNN 0.91%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.50%

IMTX -1.25%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -3.48%

INAB -1.13%

INBX -2.05%

INCY -2.20%

INDP 8.49%

INFI -52.38%

INKT 2.10%

INM 0.04%

INMB 4.48%

INO 2.86%

INSM -1.08%

INTS -1.96%

INVA 0.09%

INZY 2.06%

IOBT -10.94%

IONS 1.06%

IOVA -2.49%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.51%

ISEE 0.38%

ITOS 0.82%

ITRM 2.33%

IVA 6.96%

IVVD 0.41%

JAGX 1.31%

JANX -4.55%

JAZZ -0.92%

JNCE 0.00%

JSPR -1.92%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -4.07%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -7.91%

KPRX -2.16%

KPTI -7.80%

KRBP -10.00%

KRON 0.62%

KROS -0.55%

KRRO -0.36%

KRTX 0.03%

KRYS 0.14%

KTRA 8.01%

KTTA -0.65%

KTTAW 0.92%

KURA 0.05%

KYMR -2.83%

KYTX -3.04%

KZIA 4.41%

KZR -0.30%

LABP 0.57%

LBPH -0.54%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.98%

LENZ -2.95%

LEXX -1.56%

LEXXW -14.63%

LGND -1.29%

LGNDV 0.00%

LGVN -9.30%

LIAN -8.28%

LIFE 2.70%

LIPO -5.10%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 1.65%

LPCN -3.68%

LPTX -2.47%

LQDA 0.24%

LRMR 0.21%

LSTA -1.68%

LTRN 6.06%

LUMO 1.79%

LVTX -2.58%

LXEO -8.83%

LXRX -2.35%

LYEL -35.39%

LYRA 1.94%

MACK 0.10%

MBIO -11.00%

MBRX -1.43%

MCRB 2.55%

MDGL -2.79%

MDNA -13.16%

MDWD 2.81%

MDXG -2.36%

MEIP 0.00%

MESO -1.48%

MGNX -5.36%

MGTA -7.74%

MGTX -0.95%

MGX 0.80%

MIRM 0.00%

MIRO 0.59%

MIST 3.84%

MITO 0.00%

MLEC -7.68%

MLECW 2.31%

MLND -5.36%

MLTX 0.38%

MLYS -5.92%

MNKD -0.76%

MNMD 3.82%

MNOV 2.11%

MNPR -8.81%

MOLN 2.46%

MOR 0.45%

MORF -3.31%

MREO -2.57%

MRKR -0.42%

MRNA -8.71%

MRNS -6.25%

MRSN -2.62%

MRTX -0.17%

MRUS -0.71%

MRVI -1.02%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.48%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.00%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.70%

NKGN 10.09%

NKGNW 8.00%

NKTR 3.27%

NKTX -4.40%

NLSP 3.56%

NLSPW 26.67%

NMRA -1.26%

NMTR -42.97%

NOVN -24.84%

NRBO 14.32%

NRIX -0.65%

NRSN -4.82%

NRSNW 0.00%

NRXP -8.18%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.25%

NTRBW -31.07%

NUVL -1.49%

NVAX -7.29%

NVCT -7.75%

NVIV -34.28%

NXTC -4.11%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 10.15%

OCS -1.00%

OCUL 0.99%

OCUP 0.65%

ODT -4.27%

OKYO 2.15%

OLMA -5.20%

OMER -3.08%

OMGA 1.25%

ONCO 6.08%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 3.45%

ONTX -0.47%

ONVO 0.29%

OPNT 0.00%

OPT 2.06%

ORGS 1.19%

ORIC -0.89%

ORMP 18.32%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.26%

OVID 0.00%

OYST 0.00%

PALI -0.22%

PASG 2.63%

PBLA -7.50%

PBM -2.46%

PBYI 2.87%

PCSA -1.93%

PCVX 0.64%

PDSB -6.33%

PEPG 1.37%

PGEN -5.80%

PHAR 2.19%

PHAS 0.00%

PHAT -0.58%

PHIO -3.58%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.01%

PLUR 7.39%

PMN -5.55%

PMVP -1.79%

PNT 0.16%

PPBT -6.43%

PRAX 6.28%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.22%

PRQR 1.21%

PRTA -2.70%

PRTC 0.62%

PRTG 0.97%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.52%

PTCT -0.48%

PTE -0.82%

PTGX -0.68%

PTIXW -48.41%

PULM 1.53%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -7.18%

QNCX 5.70%

QNRX -0.49%

QSI -36.30%

QSIAW -3.13%

QTTB -0.14%

QURE -0.34%

RAIN -1.63%

RANI 4.81%

RAPT -1.62%

RARE 1.92%

RCKT -9.04%

REGN -0.47%

RENB -2.45%

REPL -1.70%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.84%

RGNX -6.49%

RIGL -6.79%

RLAY -4.60%

RLMD -1.34%

RLYB -4.70%

RNA 1.03%

RNAC -4.45%

RNAZ 0.00%

RNXT 0.88%

ROIV -1.71%

ROIVW 4.56%

RPHM -0.93%

RPRX -0.67%

RPTX -0.44%

RUBY 2.70%

RVLP -32.05%

RVMD -0.49%

RVMDW -29.90%

RVNC -0.85%

RVPH -1.07%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.23%

RYTM -5.73%

RYZB 0.02%

RZLT 2.58%

SABS -1.37%

SABSW -11.81%

SAGE 0.46%

SANA -3.41%

SAVA -1.61%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.65%

SCPH 9.85%

SCPS 0.00%

SEEL -5.07%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.60%

SGMT -4.95%

SGTX -2.56%

SIOX 22.63%

SLDB -1.89%

SLGL 5.23%

SLN -7.08%

SLNO 0.03%

SLRX 1.23%

SLS -2.99%

SMMT -3.62%

SNDX 3.07%

SNGX -0.38%

SNPX -2.56%

SONN -0.01%

SPPI -0.49%

SPRB -1.59%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.20%

SRRA 0.00%

SRRK -1.49%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -2.01%

STSA 0.00%

STTK 6.33%

SURF -0.93%

SVRA -1.58%

SWTX -0.16%

SYBX 1.29%

SYRS -1.98%

TALS -0.73%

TARA -7.38%

TARS -2.09%

TBPH 0.71%

TCBP 4.11%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 4.52%

TECH -0.83%

TENX -0.32%

TERN -9.52%

TFFP -7.61%

TGTX -6.76%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.74%

TNGX -3.35%

TNXP -6.00%

TNYA -4.74%

TPST 6.10%

TRDA -4.54%

TRVI 2.68%

TRVN 0.82%

TSHA -19.23%

TSVT -4.79%

TTNP -6.05%

TVTX 3.01%

TYRA -6.95%

UBX -2.55%

UNCY -4.20%

URGN 2.31%

UTHR 0.10%

VACC 11.36%

VALN -6.70%

VAXX 118.69%

VBIV 0.93%

VBLT -8.77%

VCEL 0.99%

VCNX 9.03%

VCYT -0.88%

VERA -6.03%

VERU 1.18%

VERV -2.29%

VIGL -2.42%

VINC 2.99%

VIR -0.60%

VIRI -4.53%

VIRX 3.98%

VKTX -1.82%

VLON -13.04%

VNDA -3.99%

VOR -6.05%

VRCA 0.00%

VRDN -3.61%

VRNA -1.66%

VRPX 1.02%

VRTX -0.03%

VSTM 3.57%

VTGN -1.66%

VTVT 0.39%

VTYX -2.72%

VXRT -2.13%

VYGR -0.77%

VYNE -3.76%

VYNT 7.78%

WINT -0.60%

WVE -8.27%

XBIO 1.03%

XBIT 7.29%

XCUR 3.77%

XENE -1.65%

XERS 4.52%

XFOR 5.73%

XLO 4.41%

XLRN 0.00%

XNCR 0.21%

XOMA -9.36%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.31%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.67%

ZNTL -1.79%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-12-29	Fairmount Funds Management Llc	Buy	406 038	Common Stock
2023-12-29	Fairmount Funds Management Llc	Sell	3 435 480	Common Stock
2023-12-22	Burrows Scott L	Buy	134 953	Common Stock
2023-12-07	Fairmount Funds Management Llc	Buy	16 667	Series B Preferred Stock
2023-11-22	Albers Jeffrey W.	Buy	50 000	Stock Option (Right to Buy)

INSIDER POWER
-5.07
Last 85 transactions
Buy: 64 136 392 \| Sell: 71 129 759

Volumen Correlación

Largo: 0.44 (neutral)

Corto: -0.73 (moderate negative)

Signal:(64.735) Neutral

Aeglea Bio Therapeutics Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aeglea Bio Therapeutics Correlación - Moneda/Commodity

-0.13
( neutral )

-0.59
( weak negative )

0.47
( neutral )

0.35
( neutral )

-0.13
( neutral )

-0.30
( neutral )

Aeglea Bio Therapeutics Finanzas

Annual	2022
Ingresos:	$2.33M
Beneficio Bruto:	$2.33M (100.00 %)
EPS:	$-24.86

FY	2022
Ingresos:	$2.33M
Beneficio Bruto:	$2.33M (100.00 %)
EPS:	$-24.86

FY	2021
Ingresos:	$18.74M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.233

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-1.520

Financial Reports:

No articles found.

Aeglea Bio Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aeglea Bio Therapeutics

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.